The elevated antioxidant capacity driven by persistent NRF2 activation and enhanced glutathione (GSH) and thioredoxin (TRX) systems enables cancer cells to withstand endogenous oxidative stress and promotes metastatic behavior
Building on the success of tirzepatidethe first approved dual GLP-1/GIP co-agonistother dual agonists, including those targeting both GLP-1 and GCG receptors, are in an advanced stage of development
People should have their backs checked regularly, as it may be harder to see moles in this area
Experimental investigations commonly focus on its interaction with glutathione peroxidases, glutathione S-transferases, and redox-sensitive signalling proteins
All professional treatments mentioned should be performed by licensed medical practitioners in Singapore, using HSA-approved products, devices, and techniques, as applicable.